Skip to main content
Caplight Logo









Tamarind Bio

Tamarind Bio

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.tamarind.bio/

Last Round

Series A

Feb 26, 2026

Total Funding Raised

$27.2M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Tamarind Bio is a biotechnology company that develops a no-code computational platform and API for drug discovery, enabling researchers to deploy and run bioinformatics models without managing complex infrastructure.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Workflow Automation, Drug Discovery, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Infrastructure

Keywords

bioinformatics infrastructuredrug discovery softwareAI inference hostingbiotech R&D platformmolecular designbio-airesearch data managementworkflow orchestrationmodel servingcheminformaticsSaaSAPI platformlab automationvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tamarind Bio Comparables

Compare Tamarind Bio with similar companies based on industry and business-model similarity.

Tamarind Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LatchBio
85%
Pluto Biosciences
82%
Benchling
79%

Tamarind Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 26, 2026
Series AMay 15, 2025
SeedJan 1, 2024

Key People

Founding team and executive leadership

Sherry Liu

Co-Founder CTO, Co-Founder

Founding Team

Deniz Kavi

Co-Founder CEO

Founding Team

Tamarind Bio Investors

Notable investors and investment history

Tamarind Bio investors
InvestorRounds
DimensionSeries A
Treeo VCSeries A
Phosphor CapitalSeries A
Y CombinatorSeed, Series A
Dimensional Fund AdvisorsSeries A
468 CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    Grew 62% QoQ, from 13 to 21 employees.

  • Jul 1, 2026

    Grew 73% QoQ, from 11 to 19 employees.

Tamarind Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tamarind Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tamarind Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range21
Year Founded2023
Last FundingFeb 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?